Attachment 1- Specialty List.xlsx
XLSX spreadsheet 18 KB Posted
- Attached to
- NPV GEN IV Draft SOW Federal contract opportunity
- Solicitation number
- SPE2DX20R0001
About this file
This document contains a draft statement of work for the upcoming National Prime Vendor Generation IV contract solicitation. The statement of work outlines requirements for the contractor to provide replenishment of pharmaceutical and pharmaceutical-related products to ordering facilities associated with the Tricare Mail Order Pharmacy, Tricare Specialty Pharmacy Network, and readiness support including War Readiness Material back-up to CONUS Pharmaceutical Prime Vendor contracts. The Defense Logistics Agency Medical Directorate is seeking industry feedback on the draft statement of work by July 24, 2020 in preparation for the upcoming solicitation to support the Defense Health Agency's TRICARE Pharmacy Program.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Attachment 2- Discrepancy Report Template.XLSX | XLSX spreadsheet | |
| SAM-NPV GEN IV Draft SOW.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| L-20 Specialty List TPharm5 | |
| Agent Name | UF class |
| ACTEMRA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| ACTHAR H.P. GEL | CORTICOSTEROIDS-IMMUNE MODULATORS |
| ACTIMMUNE | IMMUNOLOGICAL AGENTS MISCELLANEOUS |
| ADEMPAS | PULMONARY ARTERIAL HYPERTENSION |
| ADVATE | ANTIHEMOPHILIC FACTORS |
| Adynovate | ANTIHEMOPHILIC FACTORS |
| AFINITOR | ONCOLOGICAL AGENTS |
| AFSTYLA | ANTIHEMOPHILIC FACTORS |
| ALECENSA | ONCOLOGICAL AGENTS |
| ALPHANATE | ANTIHEMOPHILIC FACTORS |
| ALPHANINE | ANTIHEMOPHILIC FACTORS |
| ALPROLIX | ANTIHEMOPHILIC FACTORS |
| ALUNBRIG | ONCOLOGICAL AGENTS |
| AMPYRA | MULTIPLE SCLEROSIS AGENTS |
| APOKYN | PARKINSONS AGENTS |
| ARCALYST | TARGETED IMMUNOMODULATORY BIOLOGICS |
| AUBAGIO | MULTIPLE SCLEROSIS AGENTS |
| AUSTEDO | NEUROLOGICAL AGENTS MISCELLANEOUS |
| AVONEX | MULTIPLE SCLEROSIS AGENTS |
| BENEFIX | ANTIHEMOPHILIC FACTORS |
| BENLYSTA | IMMUNOSUPPRESSIVES |
| BETASERON | MULTIPLE SCLEROSIS AGENTS |
| BETHKIS | ANTIBIOTICS |
| BOSULIF | ONCOLOGICAL AGENTS |
| CABOMETYX | ONCOLOGICAL AGENTS |
| CALQUENCE | ONCOLOGICAL AGENTS |
| CAPECITABINE | ONCOLOGICAL AGENTS |
| CAPRELSA | ONCOLOGICAL AGENTS |
| CARBAGLU | LAXATIVES-CATHARTICS-STOOL SOFTENERS |
| CAYSTON | ANTIBIOTICS |
| CERDELGA | METABOLIC AGENTS-MISCELLANEOUS |
| CETROTIDE | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| CHENODAL | GASTROINTESTINAL-2 AGENTS |
| CHOLBAM | GASTROINTESTINAL-2 AGENTS |
| CHORIONIC GONADOTROPIN | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| CIMZIA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| COAGADEX | ANTIHEMOPHILIC FACTORS |
| COMETRIQ | ONCOLOGICAL AGENTS |
| COPAXONE | MULTIPLE SCLEROSIS AGENTS |
| COSENTYX | TARGETED IMMUNOMODULATORY BIOLOGICS |
| COTELLIC | ONCOLOGICAL AGENTS |
| CUVITRU | ANTISERA |
| CYSTADANE | METABOLIC AGENTS-MISCELLANEOUS |
| CYSTAGON | OPHTHALMIC MISCELLANEOUS |
| CYSTARAN | OPHTHALMIC MISCELLANEOUS |
| DUOPA | PARKINSONS AGENTS |
| DUPIXENT | CORTICOSTEROIDS-IMMUNE MODULATORS |
| EGRIFTA | GROWTH STIMULATING AGENTS |
| ELIGARD | LUTEINIZING HORMONE-RELEASING HORMONE AGONISTS-ANTAGONISTS |
| ELOCTATE | ANTIHEMOPHILIC FACTORS |
| EMFLAZA | CORTICOSTEROIDS-IMMUNE MODULATORS |
| ENBREL | TARGETED IMMUNOMODULATORY BIOLOGICS |
| EPCLUSA | HEPATITIS C AGENTS |
| EPIDIOLEX | ANTICONVULSANTS-ANTIMANIA AGENTS |
| ERIVEDGE | ONCOLOGICAL AGENTS |
| ERLEADA | ONCOLOGICAL AGENTS |
| ESBRIET | PULMONARY-1 AGENTS |
| EXJADE | BINDERS-CHELATORS-ANTIDOTES-OVERDOSE AGENTS |
| EXTAVIA | MULTIPLE SCLEROSIS AGENTS |
| FARYDAK | ONCOLOGICAL AGENTS |
| FASENRA | PULMONARY-1 AGENTS |
| FEIBA | ANTIHEMOPHILIC FACTORS |
| FIRAZYR | CORTICOSTEROIDS-IMMUNE MODULATORS |
| FIRMAGON | LUTEINIZING HORMONE-RELEASING HORMONE AGONISTS-ANTAGONISTS |
| FOLLISTIM | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| GAMMAGARD | ANTISERA |
| GAMMAKED | ANTISERA |
| GAMUNEX C | ANTISERA |
| GANIRELIX | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| GATTEX | GASTROINTESTINAL-2 AGENTS |
| GENOTROPIN | GROWTH STIMULATING AGENTS |
| GILENYA | MULTIPLE SCLEROSIS AGENTS |
| GILOTRIF | ONCOLOGICAL AGENTS |
| GLATIRAMER | MULTIPLE SCLEROSIS AGENTS |
| GLATOPA | MULTIPLE SCLEROSIS AGENTS |
| GLEEVEC | ONCOLOGICAL AGENTS |
| GONAL-F | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| GRANIX | WHITE BLOOD CELL STIMULANTS |
| HAEGARDA | CORTICOSTEROIDS-IMMUNE MODULATORS |
| HARVONI | HEPATITIS C AGENTS |
| HELIXATE FS | ANTIHEMOPHILIC FACTORS |
| HEMLIBRA | ANTIHEMOPHILIC FACTORS |
| HEMOFIL M | ANTIHEMOPHILIC FACTORS |
| HETLIOZ | SLEEP DISORDERS |
| HIZENTRA | ANTISERA |
| HUMATE-P | ANTIHEMOPHILIC FACTORS |
| HUMATROPE | GROWTH STIMULATING AGENTS |
| HUMIRA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| HYCAMTIN | ONCOLOGICAL AGENTS |
| HYQVIA | ANTISERA |
| IBRANCE | ONCOLOGICAL AGENTS |
| ICLUSIG | ONCOLOGICAL AGENTS |
| IDELVION | ANTIHEMOPHILIC FACTORS |
| IDHIFA | ONCOLOGICAL AGENTS |
| IMBRUVICA | ONCOLOGICAL AGENTS |
| INCRELEX | EXCLUDED FROM THE PHARMACY BENEFIT |
| INLYTA | ONCOLOGICAL AGENTS |
| INTRON A | HEPATITIS C AGENTS |
| IRESSA | ONCOLOGICAL AGENTS |
| IXINITY | ANTIHEMOPHILIC FACTORS |
| JADENU | BINDERS-CHELATORS-ANTIDOTES-OVERDOSE AGENTS |
| JAKAFI | ONCOLOGICAL AGENTS |
| JUXTAPID | ANTILIPIDEMICS-2 |
| JYNARQUE | NEPHROLOGY AGENTS MISCELLANEOUS |
| KALYDECO | CYSTIC FIBROSIS AGENTS |
| KEVEYIS | DIURETICS |
| KEVZARA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| KINERET | TARGETED IMMUNOMODULATORY BIOLOGICS |
| KISQALI | ONCOLOGICAL AGENTS |
| KITABIS | ANTIBIOTICS |
| KOATE | ANTIHEMOPHILIC FACTORS |
| KORLYM | CONTRACEPTIVE AGENTS |
| KOVALTRY | ANTIHEMOPHILIC FACTORS |
| KUVAN | METABOLIC AGENTS-MISCELLANEOUS |
| LENVIMA | ONCOLOGICAL AGENTS |
| LETAIRIS | PULMONARY ARTERIAL HYPERTENSION |
| LEUKINE | HEMATOLOGICAL AGENTS |
| LONSURF | ONCOLOGICAL AGENTS |
| LUPANETA | LUTEINIZING HORMONE-RELEASING HORMONE AGONISTS-ANTAGONISTS |
| LUPRON | LUTEINIZING HORMONE-RELEASING HORMONE AGONISTS-ANTAGONISTS |
| LYNPARZA | ONCOLOGICAL AGENTS |
| MATULANE | ONCOLOGICAL AGENTS |
| MAVYRET | HEPATITIS C AGENTS |
| MEKINIST | ONCOLOGICAL AGENTS |
| MENOPUR | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| MONONINE | ANTIHEMOPHILIC FACTORS |
| MOZOBIL | EXCLUDED FROM THE PHARMACY BENEFIT |
| MYALEPT | METABOLIC AGENTS-MISCELLANEOUS |
| NATPARA | ENDOCRINE AGENTS MISCELLANEOUS |
| NERLYNX | ONCOLOGICAL AGENTS |
| NEULASTA | WHITE BLOOD CELL STIMULANTS |
| NEUPOGEN | WHITE BLOOD CELL STIMULANTS |
| NEXAVAR | ONCOLOGICAL AGENTS |
| NINLARO | ONCOLOGICAL AGENTS |
| NITYR | METABOLIC AGENTS-MISCELLANEOUS |
| NORDITROPIN | GROWTH STIMULATING AGENTS |
| NORTHERA | CARDIOVASCULAR AGENTS MISCELLANEOUS |
| NOVAREL | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| NOVOEIGHT | ANTIHEMOPHILIC FACTORS |
| NOVOSEVEN | ANTIHEMOPHILIC FACTORS |
| NUCALA | PULMONARY-1 AGENTS |
| NUPLAZID | ANTIPSYCHOTIC AGENTS |
| NUTROPIN | GROWTH STIMULATING AGENTS |
| NUWIQ | ANTIHEMOPHILIC FACTORS |
| OBIZUR | ANTIHEMOPHILIC FACTORS |
| OCALIVA | GASTROINTESTINAL-2 AGENTS |
| OCTREOTIDE | ENDOCRINE AGENTS MISCELLANEOUS |
| ODOMZO | ONCOLOGICAL AGENTS |
| OFEV | PULMONARY-1 AGENTS |
| OLUMIANT | TARGETED IMMUNOMODULATORY BIOLOGICS |
| OMNITROPE | GROWTH STIMULATING AGENTS |
| OPSUMIT | PULMONARY ARTERIAL HYPERTENSION |
| ORALAIR | IMMUNOLOGICAL AGENTS MISCELLANEOUS |
| ORENCIA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| ORENITRAM | PULMONARY ARTERIAL HYPERTENSION |
| ORFADIN | METABOLIC AGENTS-MISCELLANEOUS |
| ORKAMBI | CYSTIC FIBROSIS AGENTS |
| OTEZLA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| OVIDREL | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| PEGASYS | HEPATITIS C AGENTS |
| PEGINTRON | HEPATITIS C AGENTS |
| PLEGRIDY | MULTIPLE SCLEROSIS AGENTS |
| POMALYST | ONCOLOGICAL AGENTS |
| PRALUENT | ANTILIPIDEMICS-1 |
| PREGNYL | FOLLICLE-STIMULATING HORMONE-LUTEINIZING HORMONE FERTILITY AGENTS |
| PROCYSBI | OPHTHALMIC MISCELLANEOUS |
| PROMACTA | ANALGESICS AND COMBINATIONS |
| PULMOZYME | RESPIRATORY AGENTS MISCELLANEOUS |
| PURIXAN | ONCOLOGICAL AGENTS |
| RAVICTI | BINDERS-CHELATORS-ANTIDOTES-OVERDOSE AGENTS |
| REBIF | MULTIPLE SCLEROSIS AGENTS |
| RECOMBINATE | ANTIHEMOPHILIC FACTORS |
| REPATHA | ANTILIPIDEMICS-1 |
| REVLIMID | ONCOLOGICAL AGENTS |
| RIBASPHERE | HEPATITIS C AGENTS |
| RIBAVIRIN | HEPATITIS C AGENTS |
| RIXUBIS | ANTIHEMOPHILIC FACTORS |
| RUBRACA | ONCOLOGICAL AGENTS |
| RYDAPT | ONCOLOGICAL AGENTS |
| SABRIL | ANTICONVULSANTS-ANTIMANIA AGENTS |
| SAIZEN | GROWTH STIMULATING AGENTS |
| SAMSCA | NEPHROLOGY AGENTS MISCELLANEOUS |
| SANDOSTATIN | ENDOCRINE AGENTS MISCELLANEOUS |
| SENSIPAR | ENDOCRINE AGENTS MISCELLANEOUS |
| SEROSTIM | GROWTH STIMULATING AGENTS |
| SIGNIFOR | ENDOCRINE AGENTS MISCELLANEOUS |
| SILIQ | TARGETED IMMUNOMODULATORY BIOLOGICS |
| SIMPONI | TARGETED IMMUNOMODULATORY BIOLOGICS |
| SOMAVERT | ENDOCRINE AGENTS MISCELLANEOUS |
| SOVALDI | HEPATITIS C AGENTS |
| SPRYCEL | ONCOLOGICAL AGENTS |
| STELARA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| STIMATE | ENDOCRINE AGENTS MISCELLANEOUS |
| STIVARGA | ONCOLOGICAL AGENTS |
| SUTENT | ONCOLOGICAL AGENTS |
| SYLATRON | HEPATITIS C AGENTS |
| SYMDEKO | CYSTIC FIBROSIS AGENTS |
| TAFINLAR | ONCOLOGICAL AGENTS |
| TAGRISSO | ONCOLOGICAL AGENTS |
| TALTZ | TARGETED IMMUNOMODULATORY BIOLOGICS |
| TARCEVA | ONCOLOGICAL AGENTS |
| TARGRETIN | ANTINEOPLASTIC AND PREMALIGNANT LESION AGENTS |
| TASIGNA | ONCOLOGICAL AGENTS |
| TAVALISSE | HEMATOLOGICAL AGENTS |
| TECFIDERA | MULTIPLE SCLEROSIS AGENTS |
| TEMODAR | ONCOLOGICAL AGENTS |
| TEMOZOLOMIDE | ONCOLOGICAL AGENTS |
| TETRABENAZINE | NEUROLOGICAL AGENTS MISCELLANEOUS |
| THALOMID | ONCOLOGICAL AGENTS |
| TOBI | ANTIBIOTICS |
| tobramycin nebulizer | ANTIBIOTICS |
| TRACLEER | PULMONARY ARTERIAL HYPERTENSION |
| TREMFYA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| TYKERB | ONCOLOGICAL AGENTS |
| TYVASO | PULMONARY ARTERIAL HYPERTENSION |
| UPTRAVI | PULMONARY ARTERIAL HYPERTENSION |
| VALCHLOR | ANTINEOPLASTIC AND PREMALIGNANT LESION AGENTS |
| VENCLEXTA | ONCOLOGICAL AGENTS |
| VENTAVIS | PULMONARY ARTERIAL HYPERTENSION |
| VERZENIO | ONCOLOGICAL AGENTS |
| VIEKIRA | HEPATITIS C AGENTS |
| VISTOGARD | BINDERS-CHELATORS-ANTIDOTES-OVERDOSE AGENTS |
| Vizimpro | ONCOLOGICAL AGENTS |
| VONVENDI | ANTIHEMOPHILIC FACTORS |
| VOSEVI | HEPATITIS C AGENTS |
| VOTRIENT | ONCOLOGICAL AGENTS |
| WILATE | ANTIHEMOPHILIC FACTORS |
| XALKORI | ONCOLOGICAL AGENTS |
| XELJANZ | TARGETED IMMUNOMODULATORY BIOLOGICS |
| XELODA | ONCOLOGICAL AGENTS |
| XENAZINE | NEUROLOGICAL AGENTS MISCELLANEOUS |
| XERMELO | GASTROINTESTINAL-2 AGENTS |
| XTANDI | ONCOLOGICAL AGENTS |
| XURIDEN | BINDERS-CHELATORS-ANTIDOTES-OVERDOSE AGENTS |
| XYNTHA | ANTIHEMOPHILIC FACTORS |
| YONSA | ONCOLOGICAL AGENTS |
| ZARXIO | WHITE BLOOD CELL STIMULANTS |
| ZAVESCA | ENDOCRINE AGENTS MISCELLANEOUS |
| ZEJULA | ONCOLOGICAL AGENTS |
| ZELBORAF | ONCOLOGICAL AGENTS |
| ZEPATIER | HEPATITIS C AGENTS |
| ZOLINZA | ONCOLOGICAL AGENTS |
| ZOMACTON | GROWTH STIMULATING AGENTS |
| ZORBTIVE | GROWTH STIMULATING AGENTS |
| ZORTRESS | ONCOLOGICAL AGENTS |
| ZYDELIG | ONCOLOGICAL AGENTS |
| ZYKADIA | ONCOLOGICAL AGENTS |
| ZYTIGA | ONCOLOGICAL AGENTS |
| ARIKAYCE | ANTIBIOTICS |
| KOGENATE FS | ANTIHEMOPHILIC FACTORS |
| ESPEROCT | ANTIHEMOPHILIC FACTORS |
| JIVI | ANTIHEMOPHILIC FACTORS |
| REBINYN | ANTIHEMOPHILIC FACTORS |
| XEMBIFY | ANTISERA |
| CUTAQUIG | IMMUNOLOGICAL AGENTS MISCELLANEOUS |
| RINVOQ | TARGETED IMMUNOMODULATORY BIOLOGICS |
| ILUMYA | TARGETED IMMUNOMODULATORY BIOLOGICS |
| SKYRIZI | TARGETED IMMUNOMODULATORY BIOLOGICS |
File details come from the government source that posted it. Updated .